These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22610132)

  • 1. Evolution of hepatitis C virus hypervariable region 1 in chronically infected children.
    Jackowiak P; Kowala-Piaskowska A; Figlerowicz M; Alejska M; Malinowska N; Figlerowicz M
    Virus Res; 2012 Aug; 167(2):380-4. PubMed ID: 22610132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of hepatitis C virus quasispecies in children with chronic hepatitis C.
    Gerotto M; Resti M; Dal Pero F; Migliorato I; Alberti A; Bortolotti F
    Infection; 2006 Apr; 34(2):62-5. PubMed ID: 16703294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversification of hypervariable region 1 of hepatitis C virus after liver transplantation.
    Fan X; Di Bisceglie AM
    J Med Virol; 2003 Jun; 70(2):212-8. PubMed ID: 12696107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
    Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
    J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy.
    Pawlotsky JM; Germanidis G; Frainais PO; Bouvier M; Soulier A; Pellerin M; Dhumeaux D
    J Virol; 1999 Aug; 73(8):6490-9. PubMed ID: 10400744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of hepatitis C virus hypervariable region 1 in immunocompetent children born to HCV-infected mothers.
    Gismondi MI; Becker PD; Díaz Carrasco JM; Guzmán CA; Campos RH; Preciado MV
    J Viral Hepat; 2009 May; 16(5):332-9. PubMed ID: 19228286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis C.
    Kurosaki M; Enomoto N; Marumo F; Sato C
    Virology; 1994 Nov; 205(1):161-9. PubMed ID: 7975211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy.
    Solmone M; Girardi E; Lalle E; Abbate I; D'Arminio Monforte A; Cozzi-Lepri A; Alessandrini A; Piscopo R; Ebo F; Cosco L; Antonucci G; Ippolito G; Capobianchi MR; ;
    Antivir Ther; 2006; 11(1):87-94. PubMed ID: 16518964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment.
    Penin F; Combet C; Germanidis G; Frainais PO; Deléage G; Pawlotsky JM
    J Virol; 2001 Jun; 75(12):5703-10. PubMed ID: 11356980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent evolution of hepatitis C virus in liver and peripheral blood mononuclear cells of infected patients.
    Maggi F; Fornai C; Morrica A; Vatteroni ML; Giorgi M; Marchi S; Ciccorossi P; Bendinelli M; Pistello M
    J Med Virol; 1999 Jan; 57(1):57-63. PubMed ID: 9890422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insertion and recombination events at hypervariable region 1 over 9.6 years of hepatitis C virus chronic infection.
    Palmer BA; Moreau I; Levis J; Harty C; Crosbie O; Kenny-Walsh E; Fanning LJ
    J Gen Virol; 2012 Dec; 93(Pt 12):2614-2624. PubMed ID: 22971825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus quasispecies in chronically infected children subjected to interferon-ribavirin therapy.
    Figlerowicz M; Jackowiak P; Formanowicz P; Kędziora P; Alejska M; Malinowska N; Błażewicz J; Figlerowicz M
    Arch Virol; 2010 Dec; 155(12):1977-87. PubMed ID: 20842394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the PKR-eIF2alpha phosphorylation homology domain (PePHD) of hepatitis C virus genotype 1 in HIV-coinfected patients by ultra-deep pyrosequencing and its relationship to responses to pegylated interferon-ribavirin treatment.
    Bolcic F; Sede M; Moretti F; Westergaard G; Vazquez M; Laufer N; Quarleri J
    Arch Virol; 2012 Apr; 157(4):703-11. PubMed ID: 22270759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2 quasispecies specificity of hepatitis C virus association with allografts immediately after liver transplantation.
    Hughes MG; Rudy CK; Chong TW; Smith RL; Evans HL; Iezzoni JC; Sawyer RG; Pruett TL
    Liver Transpl; 2004 Feb; 10(2):208-16. PubMed ID: 14762858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drift in the hypervariable region of the hepatitis C virus during 27 years in two patients.
    Gao G; Buskell Z; Seeff L; Tabor E
    J Med Virol; 2002 Sep; 68(1):60-7. PubMed ID: 12210431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cells of treatment naïve chronically infected patients.
    Vera-Otarola J; Barría MI; León U; Marsac D; Carvallo P; Soza A; López-Lastra M
    J Viral Hepat; 2009 Sep; 16(9):633-43. PubMed ID: 19254350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
    Soler M; McHutchison JG; Kwoh TJ; Dorr FA; Pawlotsky JM
    Antivir Ther; 2004 Dec; 9(6):953-68. PubMed ID: 15651754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between diversity of hepatitis C virus quasispecies and viremia, activity of liver disease and response to interferon therapy].
    Tang X; Qian K; Yuan X; Johnson YN
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):128-31. PubMed ID: 12196822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of hepatitis C virus hypervariable region 1 and its clinical significance.
    Zhang XX; Zhang SY; Liu J; Lu ZM; Wang Y
    World J Gastroenterol; 2003 May; 9(5):1003-7. PubMed ID: 12717846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive temporal mapping of hepatitis C hypervariable region 1 quasispecies provides novel insights into hepatitis C virus evolution in chronic infection.
    Schmidt-Martin D; Crosbie O; Kenny-Walsh E; Fanning LJ
    J Gen Virol; 2015 Aug; 96(8):2145-2156. PubMed ID: 25877936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.